^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    RD14-01

    i
    Other names: RD14-01
    Associations

    News

    Trials
    Company:
    Nanjing Bioheng Biotech
    Drug class:
    ROR1-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    1year
    A Study of RD14-01 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=12, Recruiting, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
    New P1/2 trial • Metastases
    |
    ROR1 (Receptor Tyrosine Kinase Like Orphan Receptor 1)
    |
    RD14-01
    over1year
    A Study of RD14-01 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=24, Not yet recruiting, Shen Lin
    New P1 trial • Metastases
    |
    ROR1 (Receptor Tyrosine Kinase Like Orphan Receptor 1)
    |
    RD14-01